Skip to content
April 19, 2024

Equity.Guru

Investment information for the new generation

Search

ALS

Forget-Me-Not Whether you believe in the metaphysical or not, there’s no denying the achievements of science. In particular, biotechnology has uncovered significant advancements in the field of medicine. For context,…
PharmaTher (PHRM.C) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also…
BrainStorm Cell Therapeutics (BCLI.Q), a biotech company involved in a research study for amyotrophic lateral sclerosis (ALS), received a combined $500,000 grant from The ALS Association and I AM…
Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to…